White House withdraws Heidi Overton’s FDA nomination

The White House withdrew Dr. Heidi Overton’s nomination to lead the FDA on Nov. 17, 2026, just before a Senate committee was scheduled to vote on it.

The administration said she lacked sufficient support. Republicans held only a one-seat advantage on the Senate Health, Education, Labor and Pensions Committee, and Democrats were expected to oppose her—leaving little room for Republican defections.

Senators had raised questions about Overton’s experience and her positions on vaccines, abortion-related policy, and other health issues. Committee chairman Bill Cassidy said he believed she could have won support and criticized the administration’s decision to pull her nomination.

Reuters reported that the White House was considering Sen. Roger Marshall as a possible replacement, but no successor had been confirmed in the reports.

Sources:

White House pulls FDA nominee Heidi Overton after wavering support from ...

White House pulls FDA nominee Heidi Overton after wavering support from ...

Trump withdraws Heidi Overton as nominee to lead Food and Drug ...

White House pulls FDA pick over lack of support

White House pulls Heidi Overton's FDA nomination ahead of Senate ...

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans

Reports: White House drops Overton as FDA leader nominee

Trump's pick Heidi Overton dropped as nominee for FDA commissioner

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans

White House drops Trump's FDA pick amid senators' opposition and 'icy' ...

White House withdraws Heidi Overton's FDA nomination on eve of Senate committee vote | Medical Economics

White House pulls Heidi Overton's FDA nomination amid GOP opposition

White House Pulls FDA Chief Nominee Before Hearing, Axios Says

Trump withdraws Heidi Overton as nominee to lead Food and Drug Administration, sources say

Trump FDA nominee Heidi Overton struggling to win enough GOP support to be confirmed